Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3681525011 | Butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg and paracetamol 325 mg oral capsule | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3681526012 | Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3681527015 | Acetaminophen 325 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg oral capsule | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | est un(e) (attribut) | Product containing only butalbital and caffeine and codeine and paracetamol in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Acetaminophen | true | Inferred relationship | Some | 3 | |
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | Butalbital (substance) | true | Inferred relationship | Some | 4 | |
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | Acetaminophen | true | Inferred relationship | Some | 3 | |
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Caffeine | true | Inferred relationship | Some | 1 | |
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | Caffeine | true | Inferred relationship | Some | 1 | |
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Plays role | Antitussive therapeutic role (role) | true | Inferred relationship | Some | ||
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | est un(e) (attribut) | Product containing butalbital (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | a pour principe actif (attribut) | Butalbital (substance) | false | Inferred relationship | Some | ||
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | est un(e) (attribut) | Acetaminophen+butalbital+caffeine+codeine phosphate | false | Inferred relationship | Some | ||
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | a pour principe actif (attribut) | Bronchodilator (substance) | false | Inferred relationship | Some | ||
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | a pour principe actif (attribut) | Codeine phosphate | false | Inferred relationship | Some | ||
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | a pour principe actif (attribut) | Codeine (substance) | false | Inferred relationship | Some | ||
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | a pour principe actif (attribut) | Morphinan opioid | false | Inferred relationship | Some | ||
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | a pour principe actif (attribut) | Caffeine | false | Inferred relationship | Some | ||
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | a pour principe actif (attribut) | analgésique non opioïde | false | Inferred relationship | Some | ||
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | a pour principe actif (attribut) | Stimulant (substance) | false | Inferred relationship | Some | ||
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | a pour principe actif (attribut) | Xanthine | false | Inferred relationship | Some | ||
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | a pour principe actif (attribut) | Acetaminophen | false | Inferred relationship | Some | ||
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | a pour principe actif (attribut) | Phosphodiesterase inhibitor | false | Inferred relationship | Some | ||
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | a une forme pharmaceutique (attribut) | Capsule | false | Inferred relationship | Some | ||
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | a pour principe actif (attribut) | Xanthine | false | Inferred relationship | Some | ||
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | a une forme pharmaceutique (attribut) | Oral capsule | true | Inferred relationship | Some | ||
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | est un(e) (attribut) | Product containing caffeine in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | est un(e) (attribut) | Codeine-containing product in oral dose form | false | Inferred relationship | Some | ||
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | est un(e) (attribut) | Acetaminophen-containing product in oral dose form | false | Inferred relationship | Some | ||
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Butalbital (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator value (attribute) | 50 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 1 | |
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Some | 1 | |
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator unit (attribute) | Capsule (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 2 | |
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Some | 2 | |
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator unit (attribute) | Capsule (unit of presentation) | true | Inferred relationship | Some | 2 | |
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 3 | |
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Some | 3 | |
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator unit (attribute) | Capsule (unit of presentation) | true | Inferred relationship | Some | 3 | |
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Acetaminophen | false | Inferred relationship | Some | 4 | |
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator value (attribute) | 325 (qualifier value) | false | Inferred relationship | Some | 4 | |
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 4 | |
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Some | 4 | |
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator unit (attribute) | Capsule (unit of presentation) | true | Inferred relationship | Some | 4 | |
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Codeine phosphate | true | Inferred relationship | Some | 2 | |
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator value (attribute) | 30 (qualifier value) | false | Inferred relationship | Some | 2 | |
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | a pour principe actif (attribut) | Caffeine | false | Inferred relationship | Some | 3 | |
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Caffeine | false | Inferred relationship | Some | 3 | |
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator value (attribute) | 40 (qualifier value) | false | Inferred relationship | Some | 3 | |
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | a pour principe actif (attribut) | Butalbital (substance) | false | Inferred relationship | Some | 4 | |
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Butalbital (substance) | true | Inferred relationship | Some | 4 | |
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator value (attribute) | 50 (qualifier value) | false | Inferred relationship | Some | 4 | |
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | a pour principe actif (attribut) | Acetaminophen | false | Inferred relationship | Some | 2 | |
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Acetaminophen | false | Inferred relationship | Some | 2 | |
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator value (attribute) | 325 (qualifier value) | false | Inferred relationship | Some | 2 | |
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | a pour principe actif (attribut) | Codeine phosphate | false | Inferred relationship | Some | 1 | |
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Codeine phosphate | false | Inferred relationship | Some | 1 | |
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator value (attribute) | 30 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | Butalbital (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | Codeine phosphate | true | Inferred relationship | Some | 2 | |
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has unit of presentation | Capsule (unit of presentation) | true | Inferred relationship | Some | ||
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | Acetaminophen | false | Inferred relationship | Some | 4 | |
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | Caffeine | false | Inferred relationship | Some | 3 | |
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | est un(e) (attribut) | Product containing butalbital and caffeine and codeine and paracetamol in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Count of base of active ingredient | quatre | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Fioricet with codeine 325mg/50mg/40mg/30mg capsule (product) | est un(e) (attribut) | False | Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR